10:29 AM EST - Emerald Health Therapeutics, Inc. : Has filed its audited financial statements and management discussion and analysis for the fiscal year ended December 31, 2017. Total revenue registered at $937,654, compared to $253,321. Net loss was $8.7 million, compared top $2.9 million. Emerald Health Therapeutics, Inc.
shares V.EMH are trading down $0.25 at $4.87.
